Grown Rogue International (GRUSF) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -304.98% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.29% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 34.33% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -189.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -189.47% |
| Sep 30, 2025 | 460,970,719.11% |
| Jan 31, 2023 | 320.41% |
| Jan 31, 2022 | 60.73% |
| Jul 31, 2021 | 93.17% |
| Apr 30, 2021 | 11.13% |
| Jan 31, 2021 | 33.08% |
| Oct 31, 2020 | 101.26% |
| Jul 31, 2020 | -4.24% |
| Apr 30, 2020 | 21.79% |
| Jan 31, 2020 | 66.47% |
| Oct 31, 2019 | 16.90% |
| Jul 31, 2019 | 47.57% |
| Apr 30, 2019 | -180.80% |
| Jan 31, 2019 | -634.88% |
| Aug 31, 2018 | 107.48% |
| May 31, 2018 | 178,137,072.15% |
| Feb 28, 2018 | -1,436,214,217.59% |
| Nov 30, 2017 | 585,693,600.39% |
| Aug 31, 2017 | -37,049.78% |